Liposomal amphotericin B followed by voriconazole for secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients

被引:0
|
作者
Allinson, K.
Kolve, H.
Gumbinger, H. G.
Vormoor, H. J.
Ehlert, K.
Groll, A. H.
机构
关键词
D O I
10.1016/S0924-8579(07)70816-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:S258 / S258
页数:1
相关论文
共 50 条
  • [31] High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
    El Cheikh, J.
    Faucher, C.
    Furst, S.
    Duran, S.
    Berger, P.
    Vey, N.
    Stoppa, A. M.
    Bouabdallah, R.
    Gastaut, J. A.
    Viens, P.
    Blaise, D.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S164 - S164
  • [32] High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
    J El-Cheikh
    C Faucher
    S Fürst
    S Duran
    P Berger
    N Vey
    A-M Stoppa
    R Bouabdallah
    J-A Gastaut
    P Viens
    D Blaise
    M Mohty
    Bone Marrow Transplantation, 2007, 39 : 301 - 306
  • [33] Voriconazole versus liposomal amphotericin B for empirical antifungal therapy - Reply
    Walsh, TJ
    Pappas, PG
    Winston, DJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22): : 1746 - 1747
  • [34] Secondary Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
    Pepeler, M. S.
    Yildiz, S.
    Yegin, Z. A.
    Ozkurt, Z. N.
    Tuncan, O. Guzel
    Erbas, G.
    Kokturk, N.
    Yildirim, Z.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S398 - S398
  • [35] Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B
    Stanzani, Marta
    Vianelli, Nicola
    Bandini, Giuseppe
    Paolini, Stefania
    Arpinati, Mario
    Bonifazi, Francesca
    Giannini, Benedetta
    Agostinelli, Claudio
    Baccarani, Michele
    Ricci, Paolo
    JOURNAL OF INFECTION, 2006, 53 (06) : E243 - E246
  • [36] Voriconazole for secondary prophylaxis of invasive fungal infection in allogeneic stem cell transplant recipients: results of the Vosifi Study
    Cordonnier, C.
    Einsele, H.
    Rovira, M.
    Maertens, J.
    Olavarria, E.
    Faucher, C.
    Cornely, O. A.
    De la Camara, R.
    Heussel, C-P
    Pineau, M.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S61 - S61
  • [37] Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
    Cordonnier, Catherine
    Rovira, Montserrat
    Maertens, Johan
    Olavarria, Eduardo
    Faucher, Catherine
    Bilger, Karin
    Pigneux, Arnaud
    Cornely, Oliver A.
    Ullmann, Andrew J.
    Bofarull, Rodrigo Martino
    de la Camara, Rafael
    Weisser, Maja
    Liakopoulou, Effie
    Abecasis, Manuel
    Heussel, Claus Peter
    Pineau, Marc
    Ljungman, Per
    Einsele, Hermann
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (10): : 1762 - 1768
  • [38] Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation
    Kolve, Hedwig
    Ahlke, Elvira
    Fegeler, Wolfgang
    Ritter, Joerg
    Juergens, Heribert
    Groll, Andreas H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) : 383 - 387
  • [39] Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study
    Ye, Peipei
    Pei, Renzhi
    Hu, Youqian
    Chen, Dong
    Li, Shuangyue
    Cao, Junjie
    Li, Fenglin
    Wu, Mengjie
    Fang, Ying
    Lu, Ying
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [40] Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study
    Peipei Ye
    Renzhi Pei
    Youqian Hu
    Dong Chen
    Shuangyue Li
    Junjie Cao
    Fenglin Li
    Mengjie Wu
    Ying Fang
    Ying Lu
    BMC Infectious Diseases, 22